Literature DB >> 20339232

ConA and UEA-I lectin histochemistry of parotid gland mucoepidermoid carcinoma.

Ana Paula V Sobral1, Moacyr J B M Rego, Carmelita L B Cavalacanti, Luiz B Carvalho, Eduardo I C Beltrão.   

Abstract

Mucoepidermoid carcinoma (MEC) corresponds to 5-12% of all salivary gland tumours, and is classified as low, intermediate or high grade. Traditionally, immunohistochemistry was considered as the complementary tool for diagnosis of salivary gland neoplasia. Lectin histochemistry has also been increasingly used in recent years. In this work, lectins were used as histochemical markers for normal and transformed parotid glands. Biopsy specimens of 15 cases diagnosed as MEC (low, intermediate and high grade) of the parotid gland were trypsin- and methanol-H(2)O(2)-treated and incubated with horseradish peroxidase (HRP)-conjugated lectins, Concanavalin A (Con A-HRP) and Ulex europeus I (UEA-I-HRP). Con A stained the neoplasic cells of MEC (all grades). In high and intermediate cases, ductal cells were weakly stained by Con A. UEA-I weakly stained normal cells of the excretory duct and neoplasic cells in high grade. Neoplasic cells in intermediate grade were moderately stained and in low grade, the cell membrane was intensely stained with UEA-I. Stroma presented a direct relation between malignancy and staining intensity for UEA-I. The results indicated that lectin histochemistry distinguished the cell biology among histological grades of MEC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339232     DOI: 10.2334/josnusd.52.49

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  7 in total

1.  Evaluation of glycophenotype in prostatic neoplasm by chemiluminescent assay.

Authors:  Lúcia Patrícia Bezerra Gomes da Silva; Sinara Mônica Vitalino de Almeida; Luiza Rayanna Amorim de Lima; Carmelita de Lima Bezerra Cavalcanti; Mariana Montenegro de Melo Lira; Maria da Paz Carvalho da Silva; Eduardo Isidoro Carneiro Beltrão; Luiz Bezerra de Carvalho Júnior
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool.

Authors:  Petra B dos-Santos; Juliana S Zanetti; Gabriela S Vieira-de-Mello; Moacyr B M Rêgo; Alfredo Ribeiro-Silva A; Eduardo Isidoro Carneiro Beltrão
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 3.  Lectins, Interconnecting Proteins with Biotechnological/Pharmacological and Therapeutic Applications.

Authors:  Luana Cassandra Breitenbach Barroso Coelho; Priscila Marcelino Dos Santos Silva; Vera Lúcia de Menezes Lima; Emmanuel Viana Pontual; Patrícia Maria Guedes Paiva; Thiago Henrique Napoleão; Maria Tereza Dos Santos Correia
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-07       Impact factor: 2.629

Review 4.  Research advances and prospects of legume lectins.

Authors:  Rajan Katoch; Ankur Tripathi
Journal:  J Biosci       Date:  2021       Impact factor: 1.826

5.  Lectins: an effective tool for screening of potential cancer biomarkers.

Authors:  Onn Haji Hashim; Jaime Jacqueline Jayapalan; Cheng-Siang Lee
Journal:  PeerJ       Date:  2017-09-07       Impact factor: 2.984

6.  Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway.

Authors:  Somsiri Indramanee; Kanlayanee Sawanyawisuth; Atit Silsirivanit; Paweena Dana; Chatchai Phoomak; Ryusho Kariya; Nathakan Klinhom-On; Supannika Sorin; Chaisiri Wongkham; Seiji Okada; Sopit Wongkham
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

Review 7.  Structure-function and application of plant lectins in disease biology and immunity.

Authors:  Abtar Mishra; Assirbad Behura; Shradha Mawatwal; Ashish Kumar; Lincoln Naik; Subhashree Subhasmita Mohanty; Debraj Manna; Puja Dokania; Amit Mishra; Samir K Patra; Rohan Dhiman
Journal:  Food Chem Toxicol       Date:  2019-09-19       Impact factor: 6.023

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.